Logo image of HLBN.DE

HOLCIM LTD (HLBN.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:HLBN - CH0012214059 - Common Stock

80.16 EUR
-0.66 (-0.82%)
Last: 12/5/2025, 7:00:00 PM
Fundamental Rating

5

HLBN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 14 industry peers in the Construction Materials industry. While HLBN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLBN has a valuation in line with the averages, but on the other hand it scores bad on growth. HLBN also has an excellent dividend rating. This makes HLBN very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HLBN was profitable.
HLBN had a positive operating cash flow in the past year.
Each year in the past 5 years HLBN has been profitable.
In the past 5 years HLBN always reported a positive cash flow from operatings.
HLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFHLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

HLBN's Return On Assets of 46.72% is amongst the best of the industry. HLBN outperforms 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 105.31%, HLBN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
HLBN has a Return On Invested Capital of 10.52%. This is in the better half of the industry: HLBN outperforms 78.57% of its industry peers.
HLBN had an Average Return On Invested Capital over the past 3 years of 6.46%. This is in line with the industry average of 7.89%.
The 3 year average ROIC (6.46%) for HLBN is below the current ROIC(10.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 46.72%
ROE 105.31%
ROIC 10.52%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
HLBN.DE Yearly ROA, ROE, ROICHLBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

The Profit Margin of HLBN (71.83%) is better than 100.00% of its industry peers.
In the last couple of years the Profit Margin of HLBN has grown nicely.
With an excellent Operating Margin value of 17.33%, HLBN belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of HLBN has grown nicely.
Looking at the Gross Margin, with a value of 44.69%, HLBN is doing worse than 64.29% of the companies in the same industry.
In the last couple of years the Gross Margin of HLBN has remained more or less at the same level.
Industry RankSector Rank
OM 17.33%
PM (TTM) 71.83%
GM 44.69%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
HLBN.DE Yearly Profit, Operating, Gross MarginsHLBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

HLBN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, HLBN has less shares outstanding
Compared to 5 years ago, HLBN has less shares outstanding
The debt/assets ratio for HLBN has been reduced compared to a year ago.
HLBN.DE Yearly Shares OutstandingHLBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
HLBN.DE Yearly Total Debt VS Total AssetsHLBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

HLBN has an Altman-Z score of 3.88. This indicates that HLBN is financially healthy and has little risk of bankruptcy at the moment.
HLBN has a Altman-Z score of 3.88. This is in the better half of the industry: HLBN outperforms 78.57% of its industry peers.
HLBN has a debt to FCF ratio of 2.67. This is a good value and a sign of high solvency as HLBN would need 2.67 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.67, HLBN is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
HLBN has a Debt/Equity ratio of 0.62. This is a neutral value indicating HLBN is somewhat dependend on debt financing.
HLBN has a worse Debt to Equity ratio (0.62) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.67
Altman-Z 3.88
ROIC/WACC2.17
WACC4.84%
HLBN.DE Yearly LT Debt VS Equity VS FCFHLBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

HLBN has a Current Ratio of 1.49. This is a normal value and indicates that HLBN is financially healthy and should not expect problems in meeting its short term obligations.
HLBN has a Current ratio (1.49) which is comparable to the rest of the industry.
A Quick Ratio of 1.21 indicates that HLBN should not have too much problems paying its short term obligations.
The Quick ratio of HLBN (1.21) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.21
HLBN.DE Yearly Current Assets VS Current LiabilitesHLBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 422.14% over the past year.
HLBN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.24% yearly.
The Revenue for HLBN has decreased by -19.77% in the past year. This is quite bad
Measured over the past years, HLBN shows a decrease in Revenue. The Revenue has been decreasing by -0.24% on average per year.
EPS 1Y (TTM)422.14%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%1046.3%
Revenue 1Y (TTM)-19.77%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-38.57%

3.2 Future

Based on estimates for the next years, HLBN will show a decrease in Earnings Per Share. The EPS will decrease by -3.75% on average per year.
HLBN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.38% yearly.
EPS Next Y-41.47%
EPS Next 2Y-20.72%
EPS Next 3Y-10.7%
EPS Next 5Y-3.75%
Revenue Next Year-39.65%
Revenue Next 2Y-21.5%
Revenue Next 3Y-13.13%
Revenue Next 5Y-5.38%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HLBN.DE Yearly Revenue VS EstimatesHLBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
HLBN.DE Yearly EPS VS EstimatesHLBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 2.70, the valuation of HLBN can be described as very cheap.
HLBN's Price/Earnings ratio is rather cheap when compared to the industry. HLBN is cheaper than 100.00% of the companies in the same industry.
HLBN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.49.
With a Price/Forward Earnings ratio of 20.33, HLBN is valued on the expensive side.
64.29% of the companies in the same industry are cheaper than HLBN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, HLBN is valued at the same level.
Industry RankSector Rank
PE 2.7
Fwd PE 20.33
HLBN.DE Price Earnings VS Forward Price EarningsHLBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HLBN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HLBN is more expensive than 71.43% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HLBN is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.58
EV/EBITDA 8.91
HLBN.DE Per share dataHLBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The excellent profitability rating of HLBN may justify a higher PE ratio.
A cheap valuation may be justified as HLBN's earnings are expected to decrease with -10.70% in the coming years.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-20.72%
EPS Next 3Y-10.7%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.12%, HLBN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.12, HLBN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, HLBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

On average, the dividend of HLBN grows each year by 39.59%, which is quite nice.
Dividend Growth(5Y)39.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

HLBN pays out 11.12% of its income as dividend. This is a sustainable payout ratio.
DP11.12%
EPS Next 2Y-20.72%
EPS Next 3Y-10.7%
HLBN.DE Yearly Income VS Free CF VS DividendHLBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
HLBN.DE Dividend Payout.HLBN.DE Dividend Payout, showing the Payout Ratio.HLBN.DE Dividend Payout.PayoutRetained Earnings

HOLCIM LTD

FRA:HLBN (12/5/2025, 7:00:00 PM)

80.16

-0.66 (-0.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)10-24 2025-10-24
Earnings (Next)02-27 2026-02-27/amc
Inst Owners42.42%
Inst Owner ChangeN/A
Ins Owners6.72%
Ins Owner ChangeN/A
Market Cap45.44B
Revenue(TTM)21.46B
Net Income(TTM)15.42B
Analysts79.29
Price Target82.48 (2.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend3.01
Dividend Growth(5Y)39.59%
DP11.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.92%
PT rev (3m)8.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.3%
EPS NY rev (3m)-2.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE 2.7
Fwd PE 20.33
P/S 1.98
P/FCF 11.58
P/OCF 8.49
P/B 2.91
P/tB 5.67
EV/EBITDA 8.91
EPS(TTM)29.72
EY37.08%
EPS(NY)3.94
Fwd EY4.92%
FCF(TTM)6.92
FCFY8.64%
OCF(TTM)9.45
OCFY11.78%
SpS40.43
BVpS27.58
TBVpS14.14
PEG (NY)N/A
PEG (5Y)0.37
Graham Number135.81
Profitability
Industry RankSector Rank
ROA 46.72%
ROE 105.31%
ROCE 13.87%
ROIC 10.52%
ROICexc 12.49%
ROICexgc 18.25%
OM 17.33%
PM (TTM) 71.83%
GM 44.69%
FCFM 17.12%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
ROICexc(3y)7.58%
ROICexc(5y)7.02%
ROICexgc(3y)13.04%
ROICexgc(5y)11.56%
ROCE(3y)8.52%
ROCE(5y)7.98%
ROICexgc growth 3Y12.63%
ROICexgc growth 5Y13.6%
ROICexc growth 3Y7.66%
ROICexc growth 5Y8.99%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.67
Debt/EBITDA 1.68
Cap/Depr 79.57%
Cap/Sales 6.24%
Interest Coverage 7.36
Cash Conversion 92.82%
Profit Quality 23.83%
Current Ratio 1.49
Quick Ratio 1.21
Altman-Z 3.88
F-Score7
WACC4.84%
ROIC/WACC2.17
Cap/Depr(3y)149.39%
Cap/Depr(5y)143.09%
Cap/Sales(3y)11.07%
Cap/Sales(5y)11.4%
Profit Quality(3y)72.22%
Profit Quality(5y)84.38%
High Growth Momentum
Growth
EPS 1Y (TTM)422.14%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%1046.3%
EPS Next Y-41.47%
EPS Next 2Y-20.72%
EPS Next 3Y-10.7%
EPS Next 5Y-3.75%
Revenue 1Y (TTM)-19.77%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-38.57%
Revenue Next Year-39.65%
Revenue Next 2Y-21.5%
Revenue Next 3Y-13.13%
Revenue Next 5Y-5.38%
EBIT growth 1Y-15.09%
EBIT growth 3Y3.69%
EBIT growth 5Y5.91%
EBIT Next Year-19.34%
EBIT Next 3Y-2.55%
EBIT Next 5Y3.43%
FCF growth 1Y835.12%
FCF growth 3Y238.03%
FCF growth 5Y4.99%
OCF growth 1Y15.53%
OCF growth 3Y3.95%
OCF growth 5Y3.27%

HOLCIM LTD / HLBN.DE FAQ

Can you provide the ChartMill fundamental rating for HOLCIM LTD?

ChartMill assigns a fundamental rating of 5 / 10 to HLBN.DE.


What is the valuation status of HOLCIM LTD (HLBN.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to HOLCIM LTD (HLBN.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for HOLCIM LTD?

HOLCIM LTD (HLBN.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of HOLCIM LTD (HLBN.DE) stock?

The Price/Earnings (PE) ratio for HOLCIM LTD (HLBN.DE) is 2.7 and the Price/Book (PB) ratio is 2.91.


Can you provide the dividend sustainability for HLBN stock?

The dividend rating of HOLCIM LTD (HLBN.DE) is 7 / 10 and the dividend payout ratio is 11.12%.